We have compared the behavior of wild-type mouse NEDD-2, a neural precursor cell-expressed, developmentally down-regulated cysteine protease gene, to various mutant forms of the gene in both apoptotic activity in neuronal cells and proteolytic cleavage in the Semliki Forest virus and rabbit reticulocyte protein expression systems. Our results confirm that NEDD-2 processing and apoptotic activity are linked phenomena. They identify aspartate residues as likely targets for autocatalytic cleavage. They establish that cleavage events only occur at specific sites. Finally, they pinpoint differential effects of individual mutations on the overall proteolytic cleavage patterns, raising interesting questions related to the mechanisms of subunit assembly.
Skip Nav Destination
Article navigation
15 October 1996
Article|
October 15 1996
Dissecting processing and apoptotic activity of a cysteine protease by mutant analysis.
B Allet,
B Allet
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
Search for other works by this author on:
A Hochmann,
A Hochmann
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
Search for other works by this author on:
I Martinou,
I Martinou
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
Search for other works by this author on:
A Berger,
A Berger
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
Search for other works by this author on:
M Missotten,
M Missotten
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
Search for other works by this author on:
B Antonsson,
B Antonsson
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
Search for other works by this author on:
R Sadoul,
R Sadoul
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
Search for other works by this author on:
J C Martinou,
J C Martinou
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
Search for other works by this author on:
L Bernasconi
L Bernasconi
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
Search for other works by this author on:
B Allet
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
A Hochmann
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
I Martinou
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
A Berger
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
M Missotten
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
B Antonsson
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
R Sadoul
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
J C Martinou
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
L Bernasconi
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., Switzerland.
Online ISSN: 1540-8140
Print ISSN: 0021-9525
J Cell Biol (1996) 135 (2): 479–486.
Citation
B Allet, A Hochmann, I Martinou, A Berger, M Missotten, B Antonsson, R Sadoul, J C Martinou, L Bernasconi; Dissecting processing and apoptotic activity of a cysteine protease by mutant analysis.. J Cell Biol 15 October 1996; 135 (2): 479–486. doi: https://doi.org/10.1083/jcb.135.2.479
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement